[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-345710-105":59,"doc-detail-345710-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","cellular-plasticity-as-a-therapeutic-vulnerability-hnf4-is-a-key-target-in-lung-adenocarcinoma","Cellular plasticity as a therapeutic vulnerability: HNF4α is a key target in lung adenocarcinoma","","The commentary explains how cellular plasticity enables cancer cells to switch differentiation states to promote malignancy and therapy escape. Focusing on invasive mucinous adenocarcinoma (IMA) of the lung, it highlights a plasticity program in which loss of NKX2-1 allows gastric identity and supports KRAS-mutant contexts. It details Dadzie et al.’s findings that HNF4α restricts FOXA1/2 activity to gastric enhancer loci via FOXA1/2 and enhances NRF2 activity to counter KRAS inhibition. These mechanistic links suggest actionable therapeutic vulnerabilities in IMA.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/cellular-plasticity-as-a-therapeutic-vulnerability-hnf4-is-a-key-target-in-lung-adenocarcinoma/345710/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/cellular-plasticity-as-a-therapeutic-vulnerability-hnf4-is-a-key-target-in-lung-adenocarcinoma/345710.png","ImageObject",300,407,{"name":92,"@type":93},"Sage","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-05","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why is cellular plasticity considered a therapeutic vulnerability in cancer?","Question",{"text":112,"@type":113},"Cellular plasticity programs allow cancer cells to alter phenotypes or differentiation states, helping them resist therapies. In this context, specific plasticity mechanisms can create dependence on particular regulators.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What role does HNF4α play in invasive mucinous adenocarcinoma (IMA) of the lung?",{"text":117,"@type":113},"HNF4α promotes gastric identity in lung epithelial cells and increases resistance to KRAS inhibition. Loss of HNF4α shifts cells away from the gastric phenotype and also slows tumor growth.",{"name":119,"@type":110,"acceptedAnswer":120},"How does HNF4α influence FOXA1/2 during gastric reprogramming?",{"text":121,"@type":113},"The findings indicate FOXA1/2 first open permissive chromatin at gastric genes, after which HNF4α enhances and reinforces FOXA1/2 binding at gastric enhancer loci. Without HNF4α, FOXA1/2 bind nongastric loci, weakening the gastric differentiation program.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},345710,1790893103,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":81,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":39,"preview_page_count":81,"preview_urls":144},687197207057,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","The Journal of Clinical Investigation COMMENTARY  \nCellular plasticity as a therapeutic vulnerability: HNF4α is a key target in lung adenocarcinoma  \nRaymond Ho1,2 and Jason C. Mills1  \n1Department of Molecular and Precision Medicine, Penn State College of Medicine, Hershey, Pennsylvania, USA. 2Medical Scientist Training Program, Baylor College of Medicine, Houston, Texas, USA.  \nCells use plasticity programs to change lineages, which aids in tissue regeneration and remodeling but also allows aberrant cells to become cancerous and escape therapy. For example, tumor cells in invasive mucinous adenocarcinoma (IMA) emerge from lung epithelial cells by a plasticity program that reprograms them into gastric epithelium–like cells. In this issue of the JCI, Dadzie et al. show that hepatocyte nuclear factor 4 α (HNF4α) promotes gastric identity in lung epithelial cells via a mechanism involving restriction of FOXA1 and FOXA2 transcription factors to gastric gene enhancer loci. HNF4α also promotes resistance to KRAS inhibition by increasing nuclear factor erythroid 2–related factor 2 (NRF2) activity. These findings may advance therapeutic avenues in IMA.  \nLung adenocarcinoma exhibits high lineage plasticity  \nCellular plasticity is a hallmark of cancer because cancer cells can use plasticity programs to change phenotypes or differentiation states to resist therapies (1) .  \nIn a specific subtype of lung cancer, invasive mucinous adenocarcinoma (IMA) of the lung, pulmonary epithelial cells can assume gastric epithelial identity because they lose the homeobox transcription factor NK2 homeobox 1 (NKX2-1, also known as TTF-1), a key specifier of normal lung epithelial development (2) . Additionally, the majority of IMAs highly express KRAS mutations (3), serving as a potential target in treatment considerations. IMAs are also characterized by expression of FOXA family transcription factors, which function as so-called “pioneer” transcription factors that help open chromatin to make it more accessible for other transcriptional modulators. In normal lung epithelial cells, NKX2-1 and FOXA1 or FOXA2 are often expressed in the same cells and coregulate cassettes of genes; however, FOXA1 and  \nFOXA2 (FOXA1/2) transcription factors are also important for epithelial cells of other organs like the stomach, intestines, and liver. It has been unclear how FOXA1/2 alone could cause IMAs to acquire gastric differentiation.  \nHNF4α drives plasticity and growth in IMA  \nLike FOXA1/2, hepatocyte nuclear factor 4 α (HNF4α) regulates gastric, intestinal, and hepatic cell differentiation (4, 5) . Moreover, it has been implicated in many different cancers as both an oncogene and tumor suppressor (6) . Interestingly, unlike NKX2-1 and FOXA1/2, HNF4α is not expressed in normal lung tissue but is expressed in IMA (7) . In previous work, Fort et al. demonstrated that when functional NKX2-1 is present in a different, non-IMA subtype of lung cancer, HNF4α regulates a mixed gastric and pulmonary cell identity (8) . However, in this issue of the JCI, Dadzie et al. showed that in IMA, the loss of NKX2-1 coupled with expression of HNF4α steered these cells specif-  \nRelated Commentary: [https://doi.org/10.1172/JCI198282](https://doi.org/10.1172/JCI198282)  \nCopyright: © 2026, Ho et al. This is an open access article published under the terms of the Creative Commons Attribution 4.0 International License.  \nReference information: J Clin Invest. 2026;136(13):e207473 . [https://doi.org/10.1172/JCI207473](https://doi.org/10.1172/JCI207473) .  \nically to the gastric phenotype (9) . Using mouse and organoid models of IMA with or without HNF4α, the authors also found that HNF4α promoted tumor growth in IMA (Figure 1A) . Thus, loss of HNF4α caused the expected drift away from gastric phenotype but also slowed tumor growth.  \nHNF4α restricts FOXA1/2 activity to gastric loci As mentioned above, previous work has shown that the pioneer transcription factors FOXA1/2 contribute to t","cbCaiehGoo7o7K2q","https://ap.wps.com/l/cbCaiehGoo7o7K2q","pdf",448419,"English","# Cellular plasticity as a therapeutic vulnerability: HNF4α in IMA\n## Lung adenocarcinoma exhibits high lineage plasticity\n## HNF4α drives plasticity and growth in IMA\n## HNF4α restricts FOXA1/2 activity to gastric loci\n## Targeting the HNF4α/NRF2 axis in IMA","[{\"question\":\"Why is cellular plasticity considered a therapeutic vulnerability in cancer?\",\"answer\":\"Cellular plasticity programs allow cancer cells to alter phenotypes or differentiation states, helping them resist therapies. In this context, specific plasticity mechanisms can create dependence on particular regulators.\"},{\"question\":\"What role does HNF4α play in invasive mucinous adenocarcinoma (IMA) of the lung?\",\"answer\":\"HNF4α promotes gastric identity in lung epithelial cells and increases resistance to KRAS inhibition. Loss of HNF4α shifts cells away from the gastric phenotype and also slows tumor growth.\"},{\"question\":\"How does HNF4α influence FOXA1/2 during gastric reprogramming?\",\"answer\":\"The findings indicate FOXA1/2 first open permissive chromatin at gastric genes, after which HNF4α enhances and reinforces FOXA1/2 binding at gastric enhancer loci. Without HNF4α, FOXA1/2 bind nongastric loci, weakening the gastric differentiation program.\"}]","Cellular plasticity as a therapeutic vulnerability: HNF4α is a key target in lung adenocarcinoma | PDF",1790058679,[145,149,153],{"page_no":8,"url":146,"width":147,"height":148},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8db440528d0afd59bc48b9bd3c7edd95.webp",983,1315,{"page_no":14,"url":150,"width":151,"height":152},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c8552be7cfc2a8818c971d3e8d577c13.webp",982,1314,{"page_no":81,"url":154,"width":155,"height":156},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ffa89c06132d1c61cb9f0770c968b9e7.webp",981,1312]